Bank of Montreal
AMRX icon

Bank of Montreal’s Amneal Pharmaceuticals AMRX Stock Holding History

Bank of Montreal’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
12,864
+2,250
+21% +$30.8K ﹤0.01% 2941
2026
Q1 		$132K Buy
+10,614
New +$143K ﹤0.01% 3059
2024
Q3 		– Sell
-36,078
Closed -$239K – 3840
2024
Q2 		$239K Buy
+36,078
New +$229K ﹤0.01% 2886
2023
Q2 		– Sell
-12,799
Closed -$24.6K – 3953
2023
Q1 		$24.6K Sell
12,799
-497
-4% -$990 ﹤0.01% 3492
2022
Q4 		$31K Buy
+13,296
New +$29.8K ﹤0.01% 3625
2021
Q2 		– Sell
-6,878
Closed -$42K – 3680
2021
Q1 		$42K Sell
6,878
-8,382
-55% -$46.5K ﹤0.01% 3778
2020
Q4 		$72K Buy
15,260
+10,678
+233% +$47.3K ﹤0.01% 3754
2020
Q3 		$19K Sell
4,582
-9,908
-68% -$42.4K ﹤0.01% 3852
2020
Q2 		$64K Buy
14,490
+10,588
+271% +$43.6K ﹤0.01% 3304
2020
Q1 		$12K Sell
3,902
-11,011
-74% -$46.6K ﹤0.01% 3413
2019
Q4 		$72K Buy
14,913
+6,697
+82% +$23.3K ﹤0.01% 3648
2019
Q3 		$24K Sell
8,216
-259
-3% -$904 ﹤0.01% 3982
2019
Q2 		$60K Buy
8,475
+3,954
+87% +$40.4K ﹤0.01% 3600
2019
Q1 		$64K Sell
4,521
-28,234
-86% -$373K ﹤0.01% 3251
2018
Q4 		$444K Buy
32,755
+627
+2% +$11.3K ﹤0.01% 2225
2018
Q3 		$713K Sell
32,128
-841
-3% -$17.7K ﹤0.01% 2157
2018
Q2 		$541K Buy
+32,969
New +$579K ﹤0.01% 2301

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Bank of Montreal's AMRX Position: Q2 2026 in Review

Bank of Montreal increased its Amneal Pharmaceuticals (AMRX) stake by 21% in Q2 2026, buying an estimated $30.8K and bringing the position to 12,864 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #2941.

Bank of Montreal first reported a position in AMRX in Q2 2018 and has held it in 17 quarters since. The position peaked at $713K in Q3 2018. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Bank of Montreal held 12,864 shares of Amneal Pharmaceuticals worth $223K as of Q2 2026.
  • Bank of Montreal bought 2,250 Amneal Pharmaceuticals shares in Q2 2026, an estimated $30.8K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2941 holding.
  • Bank of Montreal first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 17 quarters since.
  • Bank of Montreal's Amneal Pharmaceuticals position peaked at $713K in Q3 2018.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.